Global OTC Cough and Cold and Allergy Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Cough and Cold and Allergy Medicine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Very few individuals consult doctors for common conditions such as cold, cough and allergies. Cough, cold and allergy medicines are one of most common OTC (over-the-counter) categories, however, physicians recommend their use only for minor health issues. In many countries, there are certain laws enforced on directs sales of these medicines in order to ensure consumer safety.
OTC Cough and Cold and Allergy Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Cough and Cold and Allergy Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Online and Offline are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Cough and Cold and Allergy Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Cough and Cold and Allergy Medicine key manufacturers include Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group, Novartis, GlaxoSmithKline, AstraZaneca, Pfizer, Sun Pharmaceutical Industries and Prestige Brands Holdings, etc. Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group are top 3 players and held % sales share in total in 2022.
OTC Cough and Cold and Allergy Medicine can be divided into Antihistamine, Expectorants, Bronchodialators and Antibiotics, etc. Antihistamine is the mainstream product in the market, accounting for % sales share globally in 2022.
OTC Cough and Cold and Allergy Medicine is widely used in various fields, such as Online and Offline, etc. Online provides greatest supports to the OTC Cough and Cold and Allergy Medicine industry development. In 2022, global % sales of OTC Cough and Cold and Allergy Medicine went into Online filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Cough and Cold and Allergy Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi-Aventis
Johnson and Johnson
Reckitt Benckiser Group
Novartis
GlaxoSmithKline
AstraZaneca
Pfizer
Sun Pharmaceutical Industries
Prestige Brands Holdings
Procter and Gamble
Bristol-Myers Squib
Merck and Co.
Allergen
Segment by Type
Antihistamine
Expectorants
Bronchodialators
Antibiotics
Others
Online
Offline
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Cough and Cold and Allergy Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Cough and Cold and Allergy Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Cough and Cold and Allergy Medicine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of OTC Cough and Cold and Allergy Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Cough and Cold and Allergy Medicine introduction, etc. OTC Cough and Cold and Allergy Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of OTC Cough and Cold and Allergy Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
OTC Cough and Cold and Allergy Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Cough and Cold and Allergy Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Online and Offline are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Cough and Cold and Allergy Medicine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Cough and Cold and Allergy Medicine key manufacturers include Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group, Novartis, GlaxoSmithKline, AstraZaneca, Pfizer, Sun Pharmaceutical Industries and Prestige Brands Holdings, etc. Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group are top 3 players and held % sales share in total in 2022.
OTC Cough and Cold and Allergy Medicine can be divided into Antihistamine, Expectorants, Bronchodialators and Antibiotics, etc. Antihistamine is the mainstream product in the market, accounting for % sales share globally in 2022.
OTC Cough and Cold and Allergy Medicine is widely used in various fields, such as Online and Offline, etc. Online provides greatest supports to the OTC Cough and Cold and Allergy Medicine industry development. In 2022, global % sales of OTC Cough and Cold and Allergy Medicine went into Online filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Cough and Cold and Allergy Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi-Aventis
Johnson and Johnson
Reckitt Benckiser Group
Novartis
GlaxoSmithKline
AstraZaneca
Pfizer
Sun Pharmaceutical Industries
Prestige Brands Holdings
Procter and Gamble
Bristol-Myers Squib
Merck and Co.
Allergen
Segment by Type
Antihistamine
Expectorants
Bronchodialators
Antibiotics
Others
Segment by Application
Online
Offline
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Cough and Cold and Allergy Medicine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Cough and Cold and Allergy Medicine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Cough and Cold and Allergy Medicine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of OTC Cough and Cold and Allergy Medicine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Cough and Cold and Allergy Medicine introduction, etc. OTC Cough and Cold and Allergy Medicine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of OTC Cough and Cold and Allergy Medicine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.